Join
Live feed
·
INSIDERFilingvia Quantisnow
Century Therapeutics Inc. logo

SVP Finance & Operations Carr Douglas sold $544 worth of shares (275 units at $1.98), decreasing direct ownership by 0.05% to 504,819 units (SEC Form 4) (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.
IPSC· Century Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IPSC (Century Therapeutics Inc.) and more on Quantisnow.